Viewpoint

Considering R&D collaboration in China? Look before you leap, say innovation consultants Taco C.R. van Someren and Shuhua van Someren-Wang. Mistakes can cost millions.

It’s not enough to spin companies out and build them as national enterprises, says Imperial College Pro Rector Tidu Maini. The challenge is to go global – we need to scale up our thinking on science.

Building the European Research Area should be paid for by Structural Funds not R&D programmes, says Science and Technology Commissioner Janez Potočnik

The EIT finally squeaks through the Brussels bureaucracy – but more dead than alive

Science|Business editor Richard L. Hudson has a few numbers that, if you care about Europe’s future in technology markets, might make you choke on your coffee.

An R&D conference highlights the mutual incomprehension dividing industry and academics in Europe – and some suggestions for bridging the gap.

While analysts have been focusing on Asian investment in R&D, its actual research output has been missing from their radar screens. They need to refocus.

IPOs are up in the year to date. But the value of these deals is down. Rather than cashing out, VCs are getting a ticket to stay on for a white-knuckle ride.

Angelika Niebler, chair of the European Parliament committee that created the popular new European Research Council, vows to protect its political independence.

Soon it won’t be possible to fund the huge enterprises of the leading pharma companies with a handful of blockbuster drugs. The only question is whether they can change and innovate in time.